高龄患者冠状动脉旁路移植术与置入药物洗脱支架术后近远期疗效比较的Meta分析
A Meta-Analysis of Near-Long-Term Efficacy of Coronary Artery Bypass Grafting and Drug-Eluting Stent in Elderly Patients
DOI: 10.12677/HJS.2017.63004, PDF, HTML, XML, 下载: 1,335  浏览: 2,865 
作者: 单龄童, 肖雨洁, 潘毅, 魏枫:南京医科大学第一临床医学院,江苏 南京;王琪:济宁医学院法医学与医学检验学院,山东 济宁;南明明:南京医科大学护理学院,江苏 南京;王俊*:南京医科大学第一附属医院胸心外科,江苏 南京
关键词: 冠状动脉旁路移植术经皮冠状动脉介入高龄疗效meta分析Coronary Artery bypass Grafting Percutaneous Coronary Intervention Elderly Efficacy Meta-Analysis
摘要: 目的:系统评价高龄(年龄 ≥ 75岁)患者冠状动脉旁路移植术(coronary artery bypass grafting, CABG)与行经皮冠状动脉介入(percutaneous coronary intervention, PCI)下置入药物洗脱支架(drug eluting stent, DES)术后近远期疗效。方法:利用计算机检索MEDLINE(via pubmed,建库至2017年2月)、EMBASE (建库至2017年2月)、Cochrane Library (建库至2017年2月),并辅助以手动检索会议记录或灰色文献,收集研究高龄患者CABG与PCI下置入DES术后死亡率、主要不良心脑血管事件(main adverse cardiovascular and cerebrovascular events, MACCE)、心肌梗死(myocardial infarction, MI)以及靶病变再次血运重建(target lesion revascularization, TLR)发生率对比的英文文献资料。采用Review Manager 5.3软件进行meta分析。结果:共纳入12篇文献进入meta分析,均为观察性研究,未检索到随机对照研究(randomized controlled study, RCT)。本meta分析共纳入6877例患者,其中CABG组3460例(50.31%)。Meta分析结果表明:两组患者术后远期死亡率(OR = 1.29, 95%CI (1.07, 1.57), P = 0.009)以及TLR发生率(OR = 5.88, 95%CI (4.68,7.38), P < 0.00001)的差异具有统计学意义,院内死亡率(OR = 0.78, 95%CI (0.56,1.08), P = 0.14)、MACCE发生率(OR = 1.01, 95%CI (0.88, 1.17), P = 0.87)以及MI发生率(OR = 1.25, 95%CI (0.68, 2.30), P = 0.46)差异不具有统计学意义。结论:与PCI相比,CABG能明显减低高龄患者术后远期死亡率以及血运重建发生率,但仍有待于更多更大的随机对照试验以进一步验证。
Abstract: Objective: To evaluate the near-long-term efficacy of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in the elderly (age ≥ 75 years). Methods: We searched relevant literatures in MEDLINE (via pubmed), EMBASE, Cochrane Library from the time of building to 2017. Meanwhile, we collected conference records or gray literature from cardiovascular con-gresses to compare CABG and PCI for elderly patients. Meta analysis was performed using Review Manager 5.3 software. Results: A total of 12 articles were included in the meta-analysis, all of which were observational studies and randomized controlled studies (RCTs) were not retrieved. A total of 6877 patients were enrolled in this meta-analysis, of which 3460 (50.31%) were CABG. Meta- anal-ysis showed that the long-term mortality rate (OR = 1.29, 95% CI (1.07, 1.57), P = 0.009) and the in-cidence rate of revascularization (OR = 5.88, 95% CI (4.68, 7.38), P < 0.00001) have significant dif-ference between CABG group and PCI group. However, in-hospital mortality rate (OR = 0.78, 95% CI (0.56, 1.08), P = 0.14), the incidence rate of MACCE (OR = 1.01, 95% CI (0.88, 1.17), P = 0.87) and the incidence rate of MI (OR = 1.25, 95% CI (0.68, 2.30), P = 0.46) have not significant difference be-tween CABG group and PCI group. Conclusions: Compared with PCI, CABG can reduce the long-term mortality rate and the incidence rate of TLR in elderly patients, but more and more randomized controlled trials are still needed for further verification.
文章引用:单龄童, 王琪, 肖雨洁, 潘毅, 魏枫, 南明明, 王俊. 高龄患者冠状动脉旁路移植术与置入药物洗脱支架术后近远期疗效比较的Meta分析[J]. 外科, 2017, 6(3): 21-30. https://doi.org/10.12677/HJS.2017.63004

参考文献

[1] Kundi, H., Kiziltunc, E., Cetin, M., et al. (2016) Association of Monocyte/HDL-C Ratio with SYNTAX Scores in Patients with Stable Coronary Artery Disease. Herz, 41, 1-7.
https://doi.org/10.1007/s00059-015-4393-1
[2] Naghavi, M., Wang, H., Lozano, R. and Davis, A. (2013) GBD Mortality and Causes of Death Collaborators. Global, Regional, and National Levels of Age-Sex Specific All-Cause and Cause-Specific Mortality for 240 Causes of Death, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet, 385, 117-171.
[3] Moran, A.E., Forouzanfar, M.H., Roth, G.A., et al. (2014) The Global Burden of Is-chemic Heart Disease in 1990 and 2010 the Global Burden of Disease 2010 Study. Circulation, 129, 1493-1501.
https://doi.org/10.1161/CIRCULATIONAHA.113.004046
[4] Ng, M., Fleming, T., Robinson, M., et al. (2014) Global, Re-gional, and National Prevalence of Overweight and Obesity in Children and Adults during 1980-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet, 384, 766-781.
https://doi.org/10.1016/S0140-6736(14)60460-8
[5] Joanne, F., Huo, Y., Ji, L., et al. (2013) Unique and Varied Contributions of Traditional CVD Risk Factors: A Systematic Literature Review of CAD Risk Factors in China. Clinical Medicine Insights: Cardiology, 7, 59-86.
[6] Hata, J. and Kiyohara, Y. (2013) Epidemiology of Stroke and Coronary Artery Disease in Asia. Circulation Journal Official Journal of the Japanese Circulation Society, 77, 1923-1930.
https://doi.org/10.1253/circj.CJ-13-0786
[7] Park, G.M., Yun, S.C., Cho, Y.R., et al. (2015) Prevalence of Coronary Athero-sclerosis in an Asian Population: Findings from Coronary Computed Tomographic Angiography. The International Journal of Cardi-ovascular Imaging, 31, 659-668.
https://doi.org/10.1007/s10554-015-0587-0
[8] Yang, G., Wang, Y., Zeng, Y., et al. (2013) Rapid Health Transition in China, 1990-2010: Findings from the Global Burden of Disease Study 2010. The Lancet, 381, 1987-2015.
https://doi.org/10.1016/S0140-6736(13)61097-1
[9] Herlitz, J., Haglid, M., Albertsson, P., et al. (2015) Short-and Long-Term Prognosis after Coronary Artery Bypass Grafting in Relation to Smoking Habits. Cardiology, 88, 492-497.
[10] Lawton, J.S. (2002) Off-Pump Coronary Artery Bypass Grafting. The Lancet, 360, 327-330.
https://doi.org/10.1016/S0140-6736(02)09557-0
[11] Lassen, J.F., Holm, N.R., Banning, A., et al. (2016) Percutaneous Coro-nary Intervention for Coronary Bifurcation Disease: 11th Consensus Document from the European Bifurcation Club. European Society of Cardiology, 12, 38-46.
https://doi.org/10.4244/eijv12i1a7
[12] Conrotto, F., Scacciatella, P., D'Ascenzo, F., et al. (2014) Long-Term Outcomes of Per-cutaneous Coronary Interventions or Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease in Octogenarians (from a Drug- Eluting Stent for Left Main Artery Registry Substudy). American Journal of Cardiology, 113, 2007-2012.
https://doi.org/10.1016/j.amjcard.2014.03.044
[13] Bengal, Y., Finkelstein, A., Banai, S., et al. (2012) Surgical Myocardial Re-vascularization versus Percutaneous Coronary Intervention with Drug-Eluting Stents in Octogenarian Patients. Heart Surgery Forum, 15, 204-209.
https://doi.org/10.1532/HSF98.20111190
[14] Gunn, J., Kuttila, K., Vasques, F., et al. (2012) Comparison of Results of Coro-nary Artery Bypass Grafting versus Percutaneous Coronary Intervention in Octogenarians. American Journal of Cardiology, 110, 1125-1129.
[15] Rodéscabau, J., Deblois, J., Bertrand, O.F., et al. (2008) Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenari-ans. Circulation, 118, 2374-2381.
https://doi.org/10.1161/CIRCULATIONAHA.107.727099
[16] Nicolini, F., Contini, G.A., Fortuna, D., et al. (2015) Coronary Artery Surgery versus Percutaneous Coronary Intervention in Octogenarians: Long-Term Results. The Annals of Thoracic Surgery, 99, 567-574.
[17] Hannan, E.L., Zhong, Y., Berger, P.B., et al. (2014) Comparison of Intermedi-ate-Term Outcomes of Coronary Artery Bypass Grafting versus Drug-Eluting Stents for Patients ≥ 75 Years of Age. American Journal of Cardiology, 113, 803-812.
https://doi.org/10.1016/j.amjcard.2013.11.035
[18] Capodanno, D., Caggegi, A., Capranzano, P., et al. (2012) Comparative One-Year Effectiveness of Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in 2012 Patients < 75 versus ≥ 75 Years with Unprotected Left Main Disease (from the CUSTOMIZE Registry). American Journal of Cardiology, 110, 1452-1458.
https://doi.org/10.1016/j.amjcard.2012.07.005
[19] Rittger, H., Rieber, J., Kögler, K., et al. (2011) Clinical Outcome and Quality of Life after Interventional Treatment of Left Main Disease with Drug-Eluting-Stents in Comparison to CABG in Elderly and Younger Patients. Clinical Research in Cardiology, 100, 439-446.
[20] Rabeh, G.M.D., Jérôme, R.M.D., Amir, M.T.M., et al. (2009) One-Year Follow-Up of Nonrandomized Comparison between Coronary Artery Bypass Grafting Surgery and Drug-Eluting Stent for the Treatment of Unprotected Left Main Coronary Artery Disease in Elderly Patients (Aged ≥ 75 Years). Journal of Interventional Cardiology, 22, 520-526.
https://doi.org/10.1111/j.1540-8183.2009.00503.x
[21] Liu, Y.Y., Zhou, Y.J., Wang, Z.J., et al. (2009) Comparison between Drug Eluting Stent and Coronary Artery Bypass Grafting Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease in Elderly Patients. Zhong Hua Xin Xue Guan Bing Za Zhi, 24, 769-772.
[22] Palmerini, T., Barlocco, F., Santarelli, A., et al. (2007) A comparison between Coronary Artery Bypass Grafting Surgery and Drug Eluting Stent for the Treatment of Unprotected Left Main Coronary Artery Disease in Elderly Patients. Oxford University Press, Oxford.
[23] Wongcharoenkiat, N., Tresukosol, D., Lak-sanabunsong, P. and Udompunturak, S. (2012) A Comparison of Outcomes between Percutaneous Coronary Intervention versus Cor-onary Artery Bypass Surgery in Octogenarian Patients. Journal of the Medical Association of Thailand, 95, 154-168.
[24] Mahmoud, A.N., Elgendy, I.Y., Mentias, A., et al. (2017) Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting for Unpro-tected Left Main Coronary Artery Disease.
[25] Hanna, I.R. and Wenger, N.K. (2005) Secondary Prevention of Coronary Heart Dis-ease in Elderly Patients. American Family Physician, 71, 2289-2296.
[26] 陈伟伟. 中国心血管病报告2015. 中华医学信息导报. 2016(12): 11-12.
[27] Shen, W., Aguilar, R., Montero, A.R., et al. (2017) Acute Kidney Injury and in Hospital Mortality after Coro-nary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study. American Journal of Nephrology, 45, 217-230.
https://doi.org/10.1159/000455906
[28] Fanari, Z., Weiss, S.A., Zhang, W., Sonnad, S.S. and Weintraub, W.S. (2015) Comparison of Percutaneous Coronary Intervention with Drug Eluting Stents versus Coronary Artery Bypass Grafting in Patients with Multivessel Coronary Artery Disease: Meta-Analysis of Six Randomized Controlled Trials. Cardiovascular Revascularization Medi-cine Including Molecular Interventions, 16, 70-77.
https://doi.org/10.1016/j.carrev.2015.01.002
[29] Herbison, P. and Wong, C.K. (2015) Has the Difference in Mortality between Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in People with Heart Disease and Diabetes Changed over the Years? A Systematic Review and Meta-Regression. BMJ Open, 5, Article ID: 010055.
https://doi.org/10.1136/bmjopen-2015-010055